Does high-dose thiamine help fatigue and nerve pain?

Thiamine is converted in the body to thiamine pyrophosphate (TPP), a coenzyme required by three pivotal enzymes: pyruvate dehydrogenase (which feeds energy from glucose into the mitochondria), alpha-ketoglutarate dehydrogenase (a key step in the Krebs cycle), and transketolase (involved in the pentose phosphate pathway, which produces antioxidants and building blocks for DNA). When any of these enzymes slows down, the body starts backing up metabolic waste — including lactate — and tissues with high energy demands suffer first².

The brain and peripheral nerves consume glucose almost exclusively for fuel, which is why they are the first to show distress when thiamine is low. Early signs include fatigue, difficulty concentrating, irritability, and a subtle burning or numbness in the feet. Left uncorrected, deficiency progresses to full beriberi: dry beriberi manifests as peripheral neuropathy with muscle weakness, while wet beriberi involves fluid accumulation and cardiac strain¹.

Who Is at Risk

Thiamine deficiency is far more common in resource-rich countries than is generally recognized⁶. People most at risk include:

• Those who drink heavily. Alcohol blocks thiamine absorption, depletes liver stores, and impairs activation of TPP. Wernicke's encephalopathy — an acute brain emergency involving eye movement abnormalities, confusion, and ataxia — can develop rapidly and is underdiagnosed¹.
• Anyone who has had bariatric surgery. Rapid dietary change and reduced gastric acid reduce absorption significantly.
• People eating heavily processed diets. Milling removes most B1 from grains, and many convenience foods that are technically "fortified" still deliver minimal amounts.
• People taking long-term diuretics. Furosemide and other loop diuretics increase urinary thiamine excretion, and heart failure patients on these drugs show measurably lower thiamine levels⁵.
• People with eating disorders or prolonged caloric restriction. Body stores deplete within weeks.

A normal serum thiamine level does not rule out a functional deficiency. The blood test reflects free thiamine, not the intracellular or mitochondrial pools where the vitamin actually works².

High-Dose Thiamine for Fatigue and Functional Deficiency

Italian neurologist Antonio Costantini developed an approach where patients with chronic fatigue and musculoskeletal symptoms — including those with fibromyalgia, inflammatory bowel disease, and multiple sclerosis — received gram-range doses of oral thiamine (300 to 1,800 mg daily). The proposed mechanism is that a dysfunction in the transport of thiamine from blood to mitochondria can be bypassed when blood concentrations are raised high enough for passive diffusion to take over. In a published case series of three fibromyalgia patients, high-dose thiamine produced marked improvement in fatigue, pain, and sleep quality within weeks³.

This work remains preliminary — large randomized trials are lacking — but it points to a physiological rationale for why standard dietary amounts might not be sufficient in people with mitochondrial dysfunction or transport abnormalities.

Thiamine, the Heart, and Neuropathy

Heart failure patients are frequently thiamine-depleted due to a combination of diuretic use, poor appetite, and the metabolic demands of the failing heart. An updated meta-analysis of randomized controlled trials found that thiamine supplementation effectively improved thiamine deficiency status in these patients but did not significantly change left ventricular ejection fraction, concluding that it has no direct therapeutic effect on heart failure beyond correcting deficiency⁵.

For diabetic peripheral neuropathy, a study combining thiamine (25 mg/day) with pyridoxine found that 83–90% of patients reported symptom improvement in pain, numbness, and paraesthesia over four weeks, compared with 11–40% in the control group⁴. Benfotiamine — a fat-soluble thiamine precursor — achieves higher tissue concentrations and has a more robust evidence base for diabetic complications; see our Benfotiamine page for more detail.

Practical Notes

The Recommended Dietary Allowance for thiamine is 1.1–1.2 mg daily for adults, achievable from a varied whole-foods diet. Therapeutic supplementation for fatigue or neuropathy typically uses doses from 50 mg up to several hundred milligrams; at these levels thiamine is generally well-tolerated because excess is excreted in urine. Cooking destroys some thiamine (it is heat-sensitive and water-soluble), so slow-cooked or heavily boiled foods lose more than steamed or quickly cooked ones.

Cofactors matter: magnesium is required for the conversion of thiamine to its active TPP form, so magnesium deficiency can compound thiamine dysfunction even with adequate intake.

Mechanisms and deficiency syndromes — Smith et al., 2021¹

This clinical perspective published in the Annals of the New York Academy of Sciences provides a comprehensive map of thiamine deficiency disorders (TDDs). The authors describe how TDDs affect a far broader spectrum of systems than the classic neurological picture suggests: metabolic (lactic acidosis), cardiovascular (wet beriberi, high-output heart failure), respiratory, gastrointestinal, and musculoskeletal manifestations all appear. They emphasize that a low threshold for empirical thiamine supplementation is warranted because: (a) serum levels are unreliable proxies for tissue status, (b) the consequences of untreated deficiency are irreversible in some cases (Wernicke's without treatment progresses to Korsakoff's), and (c) therapeutic thiamine is safe even at high doses. The authors document that in high-income countries, risk groups extend well beyond alcoholism to include bariatric surgery patients, people with eating disorders, heavy diuretic users, and those dependent on ultra-processed food diets.

Pathophysiological mechanisms — Abdou and Hazell, 2014²

This review focuses on how thiamine deficiency damages the brain, with Wernicke's encephalopathy as the main clinical outcome. Deficiency impairs energy metabolism through mitochondrial dysfunction in focal brain regions, creating cerebral vulnerability. The consequences include oxidative stress, excitotoxicity, inflammatory responses, decreased neurogenesis, blood-brain barrier disruption, lactic acidosis and a loss of astrocyte functional integrity (including glutamate transporters), which together contribute substantially to neurodegeneration. The authors note that how these factors act together to kill neurons is unclear; they reassess their relative importance in light of recent findings and discuss therapeutic possibilities for Wernicke's encephalopathy.

High-dose thiamine for fibromyalgia — Costantini and Pala, 2013³

Three patients with fibromyalgia — a condition characterized by widespread musculoskeletal pain, severe fatigue, and sleep disturbance — received thiamine at doses determined by body weight, ranging from 600 to 1,800 mg per day orally. All three experienced significant, sustained improvement in fatigue scores and pain within 20 days, with no adverse effects. Normal serum thiamine levels at baseline suggested the benefit was not simply correcting classic deficiency but rather overcoming impaired intracellular transport through mass-action diffusion. The authors emphasize this is a case series with limited generalizability, and propose that a subset of fibromyalgia cases may represent a functional mitochondrial thiamine insufficiency rather than a systemic inflammatory disorder. Larger, controlled trials have not yet been conducted.

Thiamine, pyridoxine, and diabetic neuropathy — Abbas and Swai, 1997⁴

In a randomized comparison of 200 patients with symptomatic diabetic peripheral neuropathy in Dar es Salaam, daily supplementation with thiamine (25 mg) plus pyridoxine (50 mg) produced measurable symptom relief: 82.5–89.7% of patients reported improvement in pain, numbness, and paraesthesia at four weeks, compared with 11.1–40.5% in the control group, who took a tablet with only 1 mg of each vitamin. Peripheral neuropathy severity scores also decreased more in the treated group (48.9% vs. 11.4%). Blood thiamine levels fell as symptoms got worse (p = 0.03), and the authors concluded that diabetic neuropathy in the study population was associated with thiamine deficiency. While the doses used were relatively modest, the results suggest that correcting mild B vitamin insufficiency may be clinically meaningful in this population. The study predates modern standards for diabetic neuropathy trials and used a low-dose vitamin tablet rather than a true placebo, which limits the strength of conclusions.

Thiamine supplementation in chronic heart failure — He et al., 2024⁵

This updated meta-analysis of randomized controlled trials examined whether thiamine supplementation improves cardiac outcomes in patients with chronic heart failure. The pooled analysis of seven randomized, double-blind trials (274 patients) found that thiamine supplementation effectively improved thiamine deficiency status. It did not significantly change left ventricular ejection fraction, left ventricular end-diastolic volume, 6-minute walk distance, NT-proBNP or NYHA class compared with placebo. The authors conclude that thiamine supplementation has no direct therapeutic effect on chronic heart failure beyond correcting thiamine deficiency.

Global prevalence — Whitfield et al., 2018⁶

This report from a global expert working group estimates that thiamine deficiency is far more prevalent than acknowledged in nutrition surveys. In Southeast Asia, deficiency rates in infants and young children exceed 50% in some regions, contributing substantially to infant mortality. In high-income countries, the shift toward ultra-processed foods — which are low in thiamine even when nominally fortified — is creating pockets of subclinical deficiency. The authors advocate for better biomarker assessment and note that the gap between estimated dietary reference intakes and actual intake in vulnerable populations is larger than standard nutritional surveys capture. The review provides context for why thiamine deficiency remains clinically underrecognized even in settings with abundant food.